Baillie Gifford & CO Relay Therapeutics, Inc. Transaction History

Baillie Gifford & CO

$131 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$5.9 - $8.02 $408,091 - $554,727	-69,168 Reduced 19.58%	284,058 $1.85 Million
Q1 2024 May 01, 2024	SELL	$7.5 - $12.07 $152,775 - $245,865	-20,370 Reduced 5.45%	353,226 $2.93 Million
Q4 2023 Jan 26, 2024	SELL	$6.01 - $11.48 $125,332 - $239,403	-20,854 Reduced 5.29%	373,596 $4.11 Million
Q3 2023 Nov 13, 2023	SELL	$8.24 - $12.97 $138,909 - $218,648	-16,858 Reduced 4.1%	394,450 $3.32 Million
Q2 2023 Jul 28, 2023	SELL	$9.99 - $18.27 $43,506 - $79,565	-4,355 Reduced 1.05%	411,308 $5.17 Million
Q1 2023 May 03, 2023	BUY	$15.0 - $22.76 $17,115 - $25,969	1,141 Added 0.28%	415,663 $6.85 Million
Q4 2022 Jan 24, 2023	BUY	$14.16 - $24.02 $140,212 - $237,846	9,902 Added 2.45%	414,522 $6.19 Million
Q3 2022 Oct 27, 2022	BUY	$18.07 - $31.37 $3.34 Million - $5.8 Million	184,998 Added 84.23%	404,620 $9.05 Million
Q2 2022 Aug 08, 2022	SELL	$13.31 - $34.88 $328,158 - $859,966	-24,655 Reduced 10.09%	219,622 $3.68 Million
Q1 2022 May 05, 2022	BUY	$20.26 - $32.36 $389,721 - $622,476	19,236 Added 8.55%	244,277 $7.31 Million
Q4 2021 Jan 20, 2022	BUY	$26.0 - $37.03 $310,752 - $442,582	11,952 Added 5.61%	225,041 $6.91 Million
Q3 2021 Oct 19, 2021	BUY	$29.75 - $37.99 $611,898 - $781,378	20,568 Added 10.68%	213,089 $6.72 Million
Q2 2021 Aug 02, 2021	BUY	$27.5 - $38.19 $583,962 - $810,964	21,235 Added 12.4%	192,521 $7.04 Million
Q1 2021 May 06, 2021	BUY	$32.52 - $61.53 $2.97 Million - $5.62 Million	91,354 Added 114.29%	171,286 $5.92 Million
Q4 2020 Feb 10, 2021	SELL	$35.51 - $54.03 $198 Million - $302 Million	-5,584,989 Reduced 98.59%	79,932 $3.32 Million
Q3 2020 Nov 12, 2020	BUY	$32.81 - $45.1 $186 Million - $255 Million	5,664,921 New	5,664,921 $42.5 Million

Others Institutions Holding RLAY

# of Institutions

204

Shares Held

156M

Call Options Held

207K

Put Options Held

40K

Sb Investment Advisers (Uk) LTD London, X0

27.9M
Shares

$116 Million
1.63% of portfolio
Vanguard Group Inc Valley Forge, PA

14.5M
Shares

$60.2 Million
0.0% of portfolio
Black Rock Inc. New York, NY

10.5M
Shares

$43.9 Million
0.0% of portfolio
Casdin Capital, LLC New York, NY

9.25M
Shares

$38.5 Million
5.09% of portfolio
Bellevue Group Ag Kuesnacht, V8

7.38M
Shares

$30.7 Million
0.88% of portfolio

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $500M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account